• Nie Znaleziono Wyników

Comparison between FDG-PET/CT and bone scan in bone metastasis from NSCLC

N/A
N/A
Protected

Academic year: 2022

Share "Comparison between FDG-PET/CT and bone scan in bone metastasis from NSCLC"

Copied!
1
0
0

Pełen tekst

(1)

Letter to Editor

Comparison between FDG-PET/CT and bone scan in bone metastasis from NSCLC

Tomohiro Tamura, Katsunori Kagohashi, Koichi Kurishima, Hiroaki Satoh

Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba, Mito, Ibaraki, Japan

Contemp Oncol (Pozn) 2014; 18 (6): 452 DOI: 10.5114/wo.2014.47909

With great interest, we read the article by Inal A. et al on the comparison FDG-PET/CT and Bone scan in bone metas- tasis of NSCLC (April issue 2014, Contemporary Oncology) [1]. We would like to ask the authors two questions. First, we usually take a maximum standard uptake value into consideration in evaluating metastasis in FDG-PET/CT [2].

How about the value in this study population? How much value the authors evaluated its cutoff value in evaluating bone metastasis? Second, the majority of NSCLC patients are middle-aged or elderly, and many of them have degen- erative changes in vertebral bones, which may sometimes have uptake both in FDG-PET/CT and bone scan. How the authors differentiate metastasis from degenerative change in FDG-PET/CT and bone scan? How about the dif- ference in sensitivity and specificity in vertebral bones in their patients evaluated?

References

1. Ina A, Kaplan MA, Kucukoner M, Urakcı Z, Dostbil Z, Komek H, Onder H, Tasdemir B, Isıkdogan A. Is there any significance of lung cancer histology to compare the diagnostic accuracies of (18)F-FDG-PET/

CT and (99m)Tc-MDP BS for the detection of bone metastases in advanced NSCLC? Contemp Oncol (Pozn) 2014; 18: 106-10.

2. Hur J, Yoon CS, Ryu YH, Yun MJ, Suh JS. Accuracy of fluorodeoxy- glucose-positron emission tomography for diagnosis of single bone metastasis: comparison with bone scintigraphy. J Comput Assist Tomogr 2007; 31: 812-9.

Address for correspondence Hiroaki Satoh MD

Division of Internal Medicine, Mito Medical Center, University of Tsukuba,

Miya-machi 3-2-7, Mito, Ibaraki 310-0015 Japan

tel. +81-29-231-2371

e-mail: hirosato@md.tsukuba.ac.jp

452

Editor Note

Prior to publication of the above letter, the Editors passed it to authors [1] and asked for response. Until now it has not received. Accordingly we still expect the response.

Editor-in-Chief

Cytaty

Powiązane dokumenty

Praktyką kliniczną jest wykonywanie badania 18 F-FDG PET/CT w monitorowaniu pacjentów po leczeniu radykal- nym, w przypadku podwyższonego poziomu markerów CEA u

In the study group of 82 patients with solitary pulmonary lesions, a high sensitivity of PET-CT for predicting neoplastic character of lesion was found (95%), with a relatively

Subsequent positron emission tomography (PET)/computed tomography (CT) performed at admission documented recurrent lesion close to mesenteric artery together with an

On the basis of the presented cases we conclude that PET-CT scans with somatostatin analogue labelled with gallium ( 68 Ga-DOTA-TATE PET-CT) may be useful in the diagnostic imaging

Conclusions: Hyperprolactinaemia caused by prolactinoma in women influences bone metabolism unfavourably, more by the impact on the activity of bone turnover markers than on BMD..

Conclusions: The preoperative SUVmax measurements of the primary tumor of endometrial cancer may give additional clinical and prognostic information about risk factors and

The objective of the following study was to evaluate the predictive value of PET/CT in benign and malignant ovarian tumors and compare with computerized tomography and

Określono kierunek i siłę korelacji między gęstością mi- neralną kości szyjki udowej, wskaźnikiem metabolizmu kostnego a oznaczonymi interleukinami IL-1β i